Skip to content
Screener

ABVC BioPharma, Inc. ABVC Q3 2025 earnings

Reported October 31, 2025 · Before market open

Revenue$796.0K
EPS-$0.05

Next report

Nov 16, 2026 (in 3 months)
Revenue estimate$113.3K
EPS estimate-$0.40

FAQ

When did ABVC BioPharma, Inc. report Q3 2025 earnings?
ABVC BioPharma, Inc. (ABVC) reported Q3 2025 earnings on October 31, 2025 before market open.
What were ABVC BioPharma, Inc.'s Q3 2025 revenue and EPS?
ABVC BioPharma, Inc. reported revenue of $796.0K and eps of $-0.05 for Q3 2025.
How did ABVC BioPharma, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 104.5% from $389.3K a year earlier and eps declined 150.0% from $-0.02.
Where can I find ABVC BioPharma, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001213900-25-103799) and the 10-Q periodic report (0001213900-25-104811) directly on SEC EDGAR. The filing index links above go to sec.gov.